How many puffs in atrovent hfa

Learn more about inhalers. Learn more about nebulisers - Asthma Foundation NZ. The content on this page will be of most use to clinicians, such as nurses, doctors, pharmacists, specialists and other healthcare providers. Looking for Where to get medical help A health professional or service Patient portals Newsletters View all.

Dose The usual dose is 2 puffs inhaled four times a day, 4 to 6 hours apart 8 puffs per day. If your symptoms are severe, your doctor may ask you to increase the dose to a maximum of 12 puffs per day. Your doctor, pharmacist, or nurse will explain how to use your inhaler -- the following steps are a guide: Remove the protective cap at the plastic bottom part of the puffer.

Put mouth over plastic bottom part of the puffer AND push down on the top metal part as you breathe in. Inhale the medicine that comes out.

Hold breath for 10 seconds. Breathe out slowly. Repeat the steps for the next puff. NOTE: If your inhaler is new, it will need to be primed, by spraying 2 puffs into the atmosphere. If you have not used your inhaler for 3 days, you will need to re-prime by spraying one puff into the atmosphere.

Use only the brand of this medicine that your doctor prescribed. Different brands may not work the same way. The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Store the canister at room temperature, away from heat and direct light. Keep the sprayer pointed away from patient, other people, and pets. Pump the activator 7 times until a fine wide spray appears. If the unit has not been used for 24 hours, re-prime by pumping the activator twice. If not used for more than 7 days, re-prime as if new. Instruct patient on the proper use of nasal spray see Patient Information. After administration, rinse the tip of the spray bottle with hot water, taking care not to suck water into the bottle, and dry with a clean tissue.

Replace the cap right after cleaning. To avoid the spread of infection, do not use the sprayer for more than one person. Generic: - Protect from light - Store at room temperature between 59 to 86 degrees F - Store unused product in foil pouch Atrovent: - Protect from light - Store at room temperature between 59 to 86 degrees F - Store unused product in foil pouch.

Ipratropium inhalation aerosol contains flammable ingredients under pressure. To avoid injury, the aerosol should be kept away from extreme heat or flames and the container should not be punctured. Ipratropium is a derivative of and structurally similar to atropine; as such, use is contraindicated in patients with atropine hypersensitivity or atropine derivative hypersensitivity.

Do not use ipratropium bromide products in those with ipratropium bromide hypersensitivity. In addition, ipratropium aerosols can produce a paradoxical bronchospasm that can be life-threatening in some patients. This rare problem, when it occurs, is usually seen with the first inhalation from a newly opened canister.

Prescribers and patients should be aware of this precaution. It is recommended to 'test-spray' three times before using a new canister for the first time. If acute bronchospasm occurs during use, the ipratropium inhalation should be discontinued immediately and appropriate treatment measures instituted.

In rare cases, severe allergic reactions, including urticaria, angioedema, oropharyngeal edema, respiratory difficulty, and anaphylaxis have occurred after the use of ipratropium. All anticholinergics should be used with caution in patients with closed-angle glaucoma. Significant systemic absorption, while unlikely with ipratropium, may aggravate this condition. Ipratropium may increase intraocular pressure and aqueous outflow resistance in patients with closed-angle glaucoma, particularly if the medication gets into the eyes i.

Temporary pain, mydriasis, cycloplegia, blurred vision, conjunctivitis, or visual impairment may result from inadvertent ophthalmic administration. Care should be taken not to spray ipratropium in the eyes. The anticholinergic effects of ipratropium may make the eyes dry and this can cause irritation or blurred vision for wearers of contact lenses.

The use of lubricating drops may be necessary. Anticholinergics should be used with caution in patients with preexisting bladder obstruction of the bladder neck or other urinary tract obstruction, or in patients with prostatic hypertrophy. Ipratropium may precipitate urinary retention in patients with these conditions. Although inhaled ipratropium is only minimally absorbed into the systemic circulation, the effects of ipratropium may be additive to other concomitantly administered anticholinergic medications.

Use ipratropium with caution in patients at risk for cardiac arrhythmias. In a cohort of , asthmatics age range: 5—24 years with no history of arrhythmia or congenital heart disease, active use of an inhaled anticholinergic was associated with a 1. Risk was highest among active users of ipratropium; however, tiotropium sample size was limited.

Dizziness and blurred vision may occur with ipratropium. Should the patient experience these symptoms, the patient should use caution when engaging in activities such as driving or operating machinery. Any anticholinergic drug should be used with caution in geriatric patients.

The elderly are at greater risk for complications due to anticholinergic side effects. Although ipratropium has minimal systemic absorption, additive effects may occur in patients receiving several anticholinergic medications concurrently; if possible, avoid use of other anticholinergic medications, particularly in the geriatric patient. The OBRA guidelines caution that inhaled anticholinergic drugs, such as ipratropium, can cause xerostomia. There is limited experience with ipratropium bromide use during pregnancy; use during pregnancy only if the benefit to the mother outweighs the potential risks to the fetus.

Ipratropium is negligibly absorbed systemically following oral inhalation; maternal use is not expected to result in fetal exposure. Teratogenesis has not been reported in animals or humans with ipratropium bromide. Published literature, including cohort studies, case-control studies, and case series, over several decades have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.

Based on animal reproduction animal studies, no evidence of structural alternations was observed when ipratropium bromide was administered to pregnant mice, rats, and rabbits during organogenesis at doses up to approximately , 40,, and 10, times, respectively, the maximum recommended human daily inhalation dose MRHDID in adults. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at Do not let anyone else use your medication.

Ask your pharmacist any questions you have about refilling your prescription. It is important for you to keep a written list of all of the prescription and nonprescription over-the-counter medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements.

You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies. Ipratropium Oral Inhalation pronounced as i pra troe' pee um.

Why is this medication prescribed? How should this medicine be used? Other uses for this medicine What special precautions should I follow? What special dietary instructions should I follow? What should I do if I forget a dose? What side effects can this medication cause? What should I know about storage and disposal of this medication? Brand names. To use the inhaler, follow these steps: Hold the inhaler with the clear end pointing upward.

Place the metal canister inside the clear end of the inhaler. Be sure that it is fully and firmly in place and that the canister is at room temperature. Remove the protective dust cap from the end of the mouthpiece. If the dust cap was not placed on the mouthpiece, check the mouthpiece for dirt or other objects If you are using the inhaler for the first time or if you have not used the inhaler in 3 days, prime it by pressing down on the canister to release two sprays into the air, away from your face.

Be careful not to spray medication into your eyes while you are priming the inhaler. Breathe out as completely as possible through your mouth.

Hold the inhaler between your thumb and your next two fingers with the mouthpiece on the bottom, facing you. Place the open end of the mouthpiece into your mouth. Close your lips tightly around the mouthpiece. Close your eyes. Breathe in slowly and deeply through the mouthpiece.